UIM
WST icon

USS Investment Management’s West Pharmaceutical WST Stock Holding History

USS Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.3M Buy
123,343
+104,136
+542% +$31.8M 0.16% 81
2026
Q1 		$4.82M Buy
19,207
+721
+4% +$179K 0.02% 375
2025
Q4 		$5.09M Buy
18,486
+1,619
+10% +$443K 0.02% 356
2025
Q3 		$4.43M Hold
16,867
– – 0.02% 380
2025
Q2 		$3.69M Buy
16,867
+103
+0.6% +$22K 0.02% 411
2025
Q1 		$3.75M Hold
16,764
– – 0.03% 385
2024
Q4 		$5.49M Sell
16,764
-4,527
-21% -$1.42M 0.04% 351
2024
Q3 		$6.39M Buy
21,291
+880
+4% +$269K 0.05% 355
2024
Q2 		$6.72M Buy
20,411
+753
+4% +$266K 0.05% 294
2024
Q1 		$7.77M Sell
19,658
-2,016
-9% -$746K 0.06% 258
2023
Q4 		$7.64M Buy
21,674
+37
+0.2% +$13.1K 0.07% 246
2023
Q3 		$8.13M Buy
+21,637
New +$8.37M 0.09% 229
2022
Q3 		– Sell
-5,480
Closed -$1.66M – 701
2022
Q2 		$1.66M Sell
5,480
-1,135
-17% -$369K 0.02% 564
2022
Q1 		$2.72M Sell
6,615
-9,751
-60% -$3.82M 0.02% 538
2021
Q4 		$7.67M Hold
16,366
– – 0.06% 338
2021
Q3 		$6.95M Sell
16,366
-303,642
-95% -$128M 0.06% 337
2021
Q2 		$115M Hold
320,008
– – 0.91% 28
2021
Q1 		$90.3M Hold
320,008
– – 0.78% 31
2020
Q4 		$90.6M Hold
320,008
– – 0.82% 31
2020
Q3 		$87.9M Hold
320,008
– – 0.85% 26
2020
Q2 		$72.7M Sell
320,008
-105,540
-25% -$20.7M 0.76% 33
2020
Q1 		$65M Sell
425,548
-54,550
-11% -$8.4M 0.88% 38
2019
Q4 		$72.1M Sell
480,098
-53,422
-10% -$7.78M 0.7% 49
2019
Q3 		$75.6M Sell
533,520
-553,558
-51% -$76.2M 0.78% 41
2019
Q2 		$136M Hold
1,087,078
– – 1.4% 26
2019
Q1 		$120M Hold
1,087,078
– – 1.35% 35
2018
Q4 		$107M Hold
1,087,078
– – 1.31% 37
2018
Q3 		$134M Hold
1,087,078
– – 1.35% 31
2018
Q2 		$108M Buy
1,087,078
+214,707
+25% +$19.8M 1.18% 36
2018
Q1 		$77M Buy
+872,371
New +$81.6M 0.85% 39

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

USS Investment Management's WST Position: Q2 2026 in Review

USS Investment Management increased its West Pharmaceutical (WST) stake by 542% in Q2 2026, buying an estimated $31.8M and bringing the position to 123,343 shares worth $44.3M. The position accounts for 0.16% of the portfolio, ranked #81.

USS Investment Management first reported a position in WST in Q1 2018 and has held it in 30 quarters since. The position peaked at $136M in Q2 2019. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • USS Investment Management held 123,343 shares of West Pharmaceutical worth $44.3M as of Q2 2026.
  • USS Investment Management bought 104,136 West Pharmaceutical shares in Q2 2026, an estimated $31.8M.
  • West Pharmaceutical made up 0.16% of USS Investment Management's portfolio in Q2 2026, its #81 holding.
  • USS Investment Management first reported a position in West Pharmaceutical in Q1 2018 and has held it in 30 quarters since.
  • USS Investment Management's West Pharmaceutical position peaked at $136M in Q2 2019.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.